Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARDELYX, INC.ARDX · Entity 4972 | Chief Scientific Officer | November 22, 2021 | November 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARDELYX, INC.
Report date November 22, 2021 · Filed November 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,483 |
Ending reported balance
After 2021-11-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-11-22 · Sale · Disposed 5,000 · Balance 120,237 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. F2: This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Row 2 · 2021-11-22 · Sale · Disposed 754 · Balance 119,483 F3: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
F2: This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 754 | $0.99 | $747.89 |
DisclosureSEC source: 0001567619-21-021161 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,483 F3 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:06 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 5,000 | $0.98 | $4,881.50 |
DisclosureSEC source: 0001567619-21-021161 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 22:54 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 5,000 | $1.13 | $5,650.00 |
DisclosureSEC source: 0001567619-21-020591 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:17 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2,166 | $1.18 | $2,555.88 |
DisclosureSEC source: 0001567619-21-019728 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,237 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021. F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,166 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. F3 · balance_after: Reflects the adjusted total which includes the purchase of 2,540 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:06 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 741 | $1.32 | $978.12 |
DisclosureSEC source: 0001567619-21-016283 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,697 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC | ARDELYX, INC. ARDX · Entity 4972 | Tax withholdingCommon Stock | 5,613 | $1.64 | $9,205.32 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,438 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were granted in August 2011 and set to expire on August 11, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:00 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 10,000 | $0.54 | $5,400.00 |
DisclosureSEC source: 0001567619-21-014510 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 7,500 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F3 · derivative.exercise_date: The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 7,500 | $7.29 | $54,658.50 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,051 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:32 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 7,500 | $0.54 | $4,050.00 |
DisclosureSEC source: 0001567619-21-012329 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:47 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 721 | $7.09 | $5,110.30 |
DisclosureSEC source: 0001567619-21-010921 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,051 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F1 · shares: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:41 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 702 | $6.88 | $4,831.52 |
DisclosureSEC source: 0001567619-21-004776 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,772 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F1 · shares: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 05, 2021 Filed Jan 8, 2021 00:12 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 146,755 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001567619-21-000766 · doc1.xml · derivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,755 Underlying: Common Stock · 146,755 shares Expires 2031-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2021 Filed Jan 8, 2021 00:12 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 32,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-000766 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,474 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:10 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 3,949 | $6.88 | $27,153.32 |
DisclosureSEC source: 0001567619-20-021489 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,862 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 17, 2020. F2 · price: This transaction was executed in multiple trades in prices ranging from $6.76 to $7.04, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 22:30 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 10,000 | $6.05 | $60,500.00 |
DisclosureSEC source: 0001567619-20-016845 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,811 F4 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:30 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 40,804 | $5.53 | $225,588.99 |
DisclosureSEC source: 0001567619-20-016845 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,811 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · price: This transaction was executed in multiple trades in prices ranging from $5.30 to $5.86, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 2,049 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2020. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001140361-17-010643 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,874 Underlying: Common Stock · 3,000 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 3,000 | $13.70 | $41,100.00 |
DisclosureSEC source: 0001140361-17-010643 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,450 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 F3 · balance_after: Includes 940 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017. F2 · balance_after: Includes 17,985 restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 3,000 | $0.54 | $1,620.00 |
DisclosureSEC source: 0001140361-17-010643 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 F3 · balance_after: Includes 940 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017. F2 · balance_after: Includes 17,985 restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:09 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001140361-17-004431 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,874 Underlying: Common Stock · 3,000 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:09 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 3,000 | $12.00 | $36,000.00 |
DisclosureSEC source: 0001140361-17-004431 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,510 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:09 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 3,000 | $0.54 | $1,620.00 |
DisclosureSEC source: 0001140361-17-004431 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2016 Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 79,535 | $0.00 Strike: $13.90 | $0.00 |
DisclosureSEC source: 0001140361-17-002604 · doc1.xml · derivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,535 Underlying: Common Stock · 79,535 shares Expires 2027-01-19 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 19, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 17,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-002604 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,510 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 23:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001140361-16-082730 · doc1.xml · derivative · entry 3 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,874 Underlying: Common Stock · 6,000 shares Expires 2021-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2015. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 23:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 6,000 | $15.00 | $90,000.00 |
DisclosureSEC source: 0001140361-16-082730 · doc1.xml · nonDerivative · entry 2 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,525 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2015. F2 · balance_after: Includes an aggregate of 2,105 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016 and August 31, 2016. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 23:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 6,000 | $0.54 | $3,240.00 |
DisclosureSEC source: 0001140361-16-082730 · doc1.xml · nonDerivative · entry 1 Jacobs Jeffrey W · CIK 0001611193 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2015. F2 · balance_after: Includes an aggregate of 2,105 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016 and August 31, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.